Patents by Inventor Jonathan Solomon

Jonathan Solomon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240114822
    Abstract: A seagrass planting system that includes a planting spike. The planting spike includes: a tine end feature having a converging portion and a base portion having disposed thereon a seagrass securing mechanism for securing a seagrass segment; an alignment guide feature extending from the base portion, spanning from a first end to second end, and including a first alignment edge and a second alignment edge disposed on an area located between the first end and the second end; and force receiving feature extending at an angle relative to the second end.
    Type: Application
    Filed: June 19, 2023
    Publication date: April 11, 2024
    Applicant: REEFGEN, INC.,
    Inventors: Zachary Radding, Abhimanyu Belani, Jonathan Pompa, Madeline Pomicter, David Solomon
  • Publication number: 20220335154
    Abstract: The present disclosure provides systems, methods, and apparatuses for a predictive response-generation service to facilitate timely compliance with information-disclosure laws. When an event associated with an electronic data collection is detected, a set of features is extracted for the electronic data collection. The features are input into a machine-learning model to generate a request-prediction score. If the probability of receiving a request for data in the electronic data collection meets a threshold, a redaction operation specified by a redaction policy is executed on the electronic data collection to generate a modified electronic data collection. The modified electronic data collection, which is a redacted version of the electronic data collection, is transmitted to a digital response repository.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 20, 2022
    Inventors: FRANCESCA SCHULER, BRIAN J. FROMMELT, JAMES C. DURAN, BENJAMIN M. JORDAN, JONATHAN SOLOMON
  • Patent number: 11394680
    Abstract: Systems and methods for transmitting near real-time geographic mass messaging requests. One example method includes receiving a geographic mass messaging request via a transceiver, the geographic mass messaging request including a message, a geographic reference, and a requesting agency identifier, and having at least one request characteristic. The method includes assigning, with an electronic processor, a priority to the geographic mass messaging request based on an electronically stored alerting authority policy and at least one selected from the group consisting of the requesting agency identifier, the geographic reference, and the at least one request characteristic. The method includes, responsive to determining that the priority does not meet a priority threshold, transmitting one of a request denied message and a request modification proposal via the transceiver to the requesting agency.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: July 19, 2022
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: Francesca Schuler, James C. Duran, Jonathan Solomon
  • Patent number: 11304034
    Abstract: A communication system and method are provided for prioritizing the collection of evidence leads. Geographic mass messaging notifications are sent out alerting to an incident in conjunction with a request for incident information. Responding devices are prioritized based on device parameter information. The prioritization enables transient devices to be provided with a higher priority than non-transient devices. The assigned priority facilitates investigative follow-up of a plurality of evidence leads prior to the review of actual data content of each lead.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: April 12, 2022
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: Francesca Schuler, James C Duran, Jonathan Solomon
  • Patent number: 11261444
    Abstract: The present disclosure relates to methods of treating EPAS1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, psoriasis, Kaposi's sarcoma-associated herpesvirus, preeclampsia, inflammation, chronic inflammation, neovascular diseases, and rheumatoid arthritis, using a therapeutically effective amount of a RNAi agent to EPAS1.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: March 1, 2022
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Brian Bettencourt, Shanthi Ganesh, Elizabeth George, Dieter Huesken, Stuart Milstein, Jonathan Solomon, Emily Thomas, Ivanka Toudjarska, Jennifer Tullai, Jan Weiler
  • Publication number: 20220038411
    Abstract: Systems and methods for transmitting near real-time geographic mass messaging requests. One example method includes receiving a geographic mass messaging request via a transceiver, the geographic mass messaging request including a message, a geographic reference, and a requesting agency identifier, and having at least one request characteristic. The method includes assigning, with an electronic processor, a priority to the geographic mass messaging request based on an electronically stored alerting authority policy and at least one selected from the group consisting of the requesting agency identifier, the geographic reference, and the at least one request characteristic. The method includes, responsive to determining that the priority does not meet a priority threshold, transmitting one of a request denied message and a request modification proposal via the transceiver to the requesting agency.
    Type: Application
    Filed: May 7, 2021
    Publication date: February 3, 2022
    Inventors: Francesca Schuler, James C. Duran, Jonathan Solomon
  • Patent number: 11115369
    Abstract: Systems and methods for transmitting near real-time geographic mass messaging requests. One example method includes receiving a geographic mass messaging request via a transceiver, the geographic mass messaging request including a message, a geographic reference, and a requesting agency identifier, and having at least one request characteristic. The method includes assigning, with an electronic processor, a priority to the geographic mass messaging request based on an electronically stored alerting authority policy and at least one selected from the group consisting of the requesting agency identifier, the geographic reference, and the at least one request characteristic. The method includes, responsive to determining that the priority does not meet a priority threshold, transmitting one of a request denied message and a request modification proposal via the transceiver to the requesting agency.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: September 7, 2021
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: Francesca Schuler, James C. Duran, Jonathan Solomon
  • Patent number: 11109214
    Abstract: A device, system and method for serving interfaces to client access devices based on assigned roles is provided. A device detects an authentication of a PSAP user via a client access device and retrieves a PSAP load. The PSAP load may be a current and/or historical call-taking load, and/or a current and/or historical first-responder dispatching load. The device assigns, based on the PSAP load, a role to the PSAP user, the role comprising one of: a call-taking role; a first-responder-dispatching role; and a combined call-taking and first-responder-dispatching role. The device serves, to the client access device, based on the role assigned to the PSAP user, a corresponding interface to one of: a call-taking application; a first-responder-dispatching application; and a combined call-taking and first-responder-dispatching application.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: August 31, 2021
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: Samuel Claybrook, Jonathan Solomon, Joshua Smith
  • Publication number: 20200190517
    Abstract: The present disclosure relates to methods of treating EPAS1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, psoriasis, Kaposi's sarcoma-associated herpesvirus, preemclampsia, inflammation, chronic inflammation, neovascular diseases, and rheumatoid arthritis, using a therapeutically effective amount of a RNAi agent to EPAS1.
    Type: Application
    Filed: January 21, 2020
    Publication date: June 18, 2020
    Inventors: Brian Bettencourt, Shanthi Ganesh, Elizabeth George, Dleter Heusken, Stuart Milstein, JR., Jonathan Solomon, Emily Thomas, Ivanka Toudjarska, Jennifer Tullai, Jan Weiler
  • Patent number: 10538765
    Abstract: The present disclosure relates to methods of treating EPAS1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, psoriasis, Kaposi's sarcoma-associated herpesvirus, preemclampsia, inflammation, chronic imflammation, neovascular diseases, and rheumatoid arthritis, using a therapeutically effective amount of a RNAi agent to EPAS1.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: January 21, 2020
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Brian Bettencourt, Shanthi Ganesh, Elizabeth George, Dieter Huesken, Stuart Milstein, Jonathan Solomon, Emily Thomas, Ivanka Toudjarska, Jennifer Tullai, Jan Weiler
  • Publication number: 20180100151
    Abstract: The present disclosure relates to methods of treating EPAS1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, rheumatoid arthritis, using a therapeutically effective amount of a RNAi agent to EPAS1.
    Type: Application
    Filed: December 7, 2017
    Publication date: April 12, 2018
    Inventors: Brian Bettencourt, Shanthi Ganesh, Elizabeth George, Dieter Heusken, Stuart Milstein, Jonathan Solomon, Emily Thomas, Ivanka Toudjarska, Jennifer Tullai, Jan Weiler
  • Patent number: 9868949
    Abstract: The present disclosure relates to methods of treating EPAS1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, psoriasis, Kaposi's sarcoma-associated herpesvirus, preemclampsia, inflammation, chronic inflammation, neovascular diseases, and rheumatoid arthritis, using a therapeutically effective amount of a RNAi agent to EPAS1.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: January 16, 2018
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Brian Bettencourt, Shanthi Ganesh, Elizabeth George, Dieter Heusken, Stuart Milstein, Jonathan Solomon, Emily Thomas, Ivanka Toudjarska, Jennifer Tullai, Jan Weiler
  • Publication number: 20160010089
    Abstract: The present disclosure relates to methods of treating EPAS1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, psoriasis, Kaposi's sarcoma-associated herpesvirus, preemclampsia, inflammation, chronic inflammation, neovascular diseases, and rheumatoid arthritis, using a therapeutically effective amount of a RNAi agent to EPAS1.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Inventors: Brian Bettencourt, Shanthi Ganesh, Elizabeth George, Dieter Huesken, Stuart Milstein, Jonathan Solomon, Emily Thomas, Ivanka Toudjarska, Jennifer Tullai, Jan Weiler
  • Patent number: 7800683
    Abstract: A method and system are presented for imaging an object with image resolution for at least a part of the object exceeding by a predetermined factor a geometrical resolution defined by a detector pixel array. A predetermined aperture coding is applied to the wavefront of a light signal indicative of at least a part of the object to be imaged with the enhanced resolution, while propagating towards the detector pixel array. The aperture coding is predetermined in accordance with aliasing occurring in the detector plane and such as to provide orthogonality of spectral data indicative of a sampled output of the detector, to thereby enable using the aperture code to reconstruct the image of said at least part of the object with the resolution enhanced by said factor.
    Type: Grant
    Filed: May 13, 2004
    Date of Patent: September 21, 2010
    Assignee: Xceed Imaging Ltd.
    Inventors: Zeev Zalevsky, Jonathan Solomon
  • Publication number: 20070040828
    Abstract: A method and system are presented for imaging an object with image resolution for at least a part of the object exceeding by a predetermined factor a geometrical resolution defined by a detector pixel array. A predetermined aperture coding is applied to the wavefront of a light signal indicative of at least a part of the object to be imaged with the enhanced resolution, while propagating towards the detector pixel array. The aperture coding is predetermined in accordance with aliasing occurring in the detector plane and such as to provide orthogonality of spectral data indicative of a sampled output of the detector, to thereby enable using the aperture code to reconstruct the image of said at least part of the object with the resolution enhanced by said factor.
    Type: Application
    Filed: May 13, 2004
    Publication date: February 22, 2007
    Applicant: ECEED IMAGING LTD.
    Inventors: Zeev Zalevsky, Jonathan Solomon
  • Publication number: 20060074124
    Abstract: Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
    Type: Application
    Filed: March 11, 2005
    Publication date: April 6, 2006
    Inventors: Andrew Napper, Peter Distefano, Rory Curtis, Jeffrey Hixon, Thomas McDonagh, L. Huber, Jonathan Solomon, Russell Thomas, Jean-Francois Pons
  • Publication number: 20060051767
    Abstract: Modulation of cytochrome c acetylation, e.g., with a SIR polypeptide, enables interventions that modulate lifespan regulation and cell proliferation, e.g., by modulating apoptosis and/or mitochondrial function such as respiration.
    Type: Application
    Filed: December 15, 2003
    Publication date: March 9, 2006
    Inventors: L Huber, Jonathan Solomon
  • Publication number: 20050209300
    Abstract: Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
    Type: Application
    Filed: September 13, 2004
    Publication date: September 22, 2005
    Inventors: Andrew Napper, Peter Distefano, Rory Curtis, Jeffrey Hixon, Thomas McDonagh, L. Huber, Jonathan Solomon, Russell Thomas, Jean-Francois Pons
  • Publication number: 20030177171
    Abstract: According to one embodiment, the invention provides a method for operating an electronic mail server system having mailboxes associated with message client devices. The method comprises receiving input to change a mailbox, said input comprising a request to change an organizational structure of the mailbox; making changes to the mailbox in response to said input; and sending a message to a message client device associated with the mailbox, the message comprising information to allow the message client device to synchronize a cached version of the mailbox stored locally in the message client device with the mailbox.
    Type: Application
    Filed: January 22, 2002
    Publication date: September 18, 2003
    Inventors: Bruce Loring Brown, Benjamin Jonathan Solomon Ellsworth